Skip to main content
Erschienen in: Archives of Gynecology and Obstetrics 4/2009

01.10.2009 | Original Article

Severity of pain and circadian changes in uterine artery blood flow in primary dysmenorrhea

verfasst von: Husnu Celik, Bilgin Gurates, Cem Parmaksiz, Aytac Polat, Fethi Hanay, Burcin Kavak, Adem Yavuz, Zeynep Dogan Artas

Erschienen in: Archives of Gynecology and Obstetrics | Ausgabe 4/2009

Einloggen, um Zugang zu erhalten

Abstract

Objective

To investigate the severity of pain and circadian changes in uterine artery blood flow in primary dysmenorrhea cases.

Materials and methods

The study included 27 cases diagnosed as primary dysmenorrhea and 25 individuals who had no dysmenorrhea complaint. Bilateral uterine artery systole/diastole rates (S/D), pulsatility indices (PI) and resistance indices (RI) of all cases were measured using transvaginal colour Doppler at 12.00–02.00 p.m. and 12.00–02.00 a.m. Severity of pain was evaluated in dysmenorrhea cases at the same hours using a verbal pain assessment scale.

Findings

Doppler measurements of dysmenorrhea cases conducted at 12.00–02.00 p.m. showed right uterine artery S/D: 3.37 ± 0.26, RI: 0.73 ± 0.07, PI: 2.38 ± 0.34 and left uterine artery S/D: 3.33 ± 0.37, RI: 0.74 ± 0.14, PI: 2.41 ± 0.15, while measurements carried out at 12.00–02.00 a.m. showed right uterine artery S/D: 3.88 ± 0.12, RI: 0.87 ± 0.14, PI: 2.94 ± 0.21 and left uterine artery S/D: 3.90 ± 0.27, RI: 0.92 ± 0.12, PI: 2.93 ± 0.21. Comparisons revealed significantly higher Doppler indices at night (P < 0.05) than in the day in dysmenorrhea cases. There was not any significant circadian difference in individuals who did not have dysmenorrhea (P > 0.05). Pain score in the verbal pain assessment of dysmenorrhea cases was found 3.6 ± 1.4 in the day and 5.8 ± 1.7 at night. The difference was found significant (P < 0.05).

Conclusion

Uterine artery blood flow is reduced at night in dysmenorrhea cases. In correlation with this, the cases feel more pain at night. Our results may be important on the planning of working hours and their quality of life.
Literatur
1.
Zurück zum Zitat Coco AS (1999) Primary dysmenorrhea. Am Fam Physician 60:489–496PubMed Coco AS (1999) Primary dysmenorrhea. Am Fam Physician 60:489–496PubMed
2.
Zurück zum Zitat Strömberg P, Akerlund M, Forsling ML, Granström E, Kindahl H (1984) Vasopressin and prostaglandins in premenstrual pain and primary dysmenorrhea. Acta Obstet Gynecol Scand 63:533–538PubMed Strömberg P, Akerlund M, Forsling ML, Granström E, Kindahl H (1984) Vasopressin and prostaglandins in premenstrual pain and primary dysmenorrhea. Acta Obstet Gynecol Scand 63:533–538PubMed
5.
Zurück zum Zitat Zaidi J, Jurkovic D, Campbell S, Pittrof R, McGregor A, Tan SL (1995) Description of circadian rhythm in uterine artery blood flow during the peri-ovulatory period. Hum Reprod 10:1642–1646PubMedCrossRef Zaidi J, Jurkovic D, Campbell S, Pittrof R, McGregor A, Tan SL (1995) Description of circadian rhythm in uterine artery blood flow during the peri-ovulatory period. Hum Reprod 10:1642–1646PubMedCrossRef
6.
Zurück zum Zitat Lundstrom V, Eneroth P, Swahn ML (1984) Diurnal variation of uterine contractility. Br J Obstet Gynaecol 91:155–159PubMed Lundstrom V, Eneroth P, Swahn ML (1984) Diurnal variation of uterine contractility. Br J Obstet Gynaecol 91:155–159PubMed
7.
Zurück zum Zitat Sundell G, Milsom I, Andersch B (1990) Factors influencing the prevalence and severity of dysmenorrhoea in young women. Br J Obstet Gynaecol 97:588–594PubMed Sundell G, Milsom I, Andersch B (1990) Factors influencing the prevalence and severity of dysmenorrhoea in young women. Br J Obstet Gynaecol 97:588–594PubMed
9.
Zurück zum Zitat Smith RP (1993) Cyclic pelvic pain and dysmenorrhea. Obstet Gynecol Clin North Am 20:753–764PubMed Smith RP (1993) Cyclic pelvic pain and dysmenorrhea. Obstet Gynecol Clin North Am 20:753–764PubMed
10.
Zurück zum Zitat Eden JA (1998) Dysmenorrhea and premenstrual syndrome. In: Hacker NF, Moore JG (eds) Essentials of obstetrics and gynecology, 3rd edn. WB Saunders, Philadelphia, pp 386–392 Eden JA (1998) Dysmenorrhea and premenstrual syndrome. In: Hacker NF, Moore JG (eds) Essentials of obstetrics and gynecology, 3rd edn. WB Saunders, Philadelphia, pp 386–392
11.
Zurück zum Zitat Akerlund M (1979) Pathophysiology of dysmenorrhea. Acta Obstet Gynecol Scand Suppl 87:27–32PubMed Akerlund M (1979) Pathophysiology of dysmenorrhea. Acta Obstet Gynecol Scand Suppl 87:27–32PubMed
16.
Zurück zum Zitat Klein JR, Litt IF (1981) Epidemiology of adolescent dysmenorrhea. Pediatrics 68:661–664PubMed Klein JR, Litt IF (1981) Epidemiology of adolescent dysmenorrhea. Pediatrics 68:661–664PubMed
17.
Zurück zum Zitat Dawood MY (1984) Ibuprofen and dysmenorrhea. Am J Med 77:87–94PubMed Dawood MY (1984) Ibuprofen and dysmenorrhea. Am J Med 77:87–94PubMed
18.
Zurück zum Zitat Harel Z (2006) Dysmenorrhea in adolescents and young adults: etiology and management. J Pediatr Adolesc Gynecol 19:363–371PubMedCrossRef Harel Z (2006) Dysmenorrhea in adolescents and young adults: etiology and management. J Pediatr Adolesc Gynecol 19:363–371PubMedCrossRef
Metadaten
Titel
Severity of pain and circadian changes in uterine artery blood flow in primary dysmenorrhea
verfasst von
Husnu Celik
Bilgin Gurates
Cem Parmaksiz
Aytac Polat
Fethi Hanay
Burcin Kavak
Adem Yavuz
Zeynep Dogan Artas
Publikationsdatum
01.10.2009
Verlag
Springer-Verlag
Erschienen in
Archives of Gynecology and Obstetrics / Ausgabe 4/2009
Print ISSN: 0932-0067
Elektronische ISSN: 1432-0711
DOI
https://doi.org/10.1007/s00404-009-0966-7

Weitere Artikel der Ausgabe 4/2009

Archives of Gynecology and Obstetrics 4/2009 Zur Ausgabe

Blutdrucksenkung könnte Uterusmyome verhindern

Frauen mit unbehandelter oder neu auftretender Hypertonie haben ein deutlich erhöhtes Risiko für Uterusmyome. Eine Therapie mit Antihypertensiva geht hingegen mit einer verringerten Inzidenz der gutartigen Tumoren einher.

Antikörper-Wirkstoff-Konjugat hält solide Tumoren in Schach

16.05.2024 Zielgerichtete Therapie Nachrichten

Trastuzumab deruxtecan scheint auch jenseits von Lungenkrebs gut gegen solide Tumoren mit HER2-Mutationen zu wirken. Dafür sprechen die Daten einer offenen Pan-Tumor-Studie.

Mammakarzinom: Senken Statine das krebsbedingte Sterberisiko?

15.05.2024 Mammakarzinom Nachrichten

Frauen mit lokalem oder metastasiertem Brustkrebs, die Statine einnehmen, haben eine niedrigere krebsspezifische Mortalität als Patientinnen, die dies nicht tun, legen neue Daten aus den USA nahe.

S3-Leitlinie zur unkomplizierten Zystitis: Auf Antibiotika verzichten?

15.05.2024 Harnwegsinfektionen Nachrichten

Welche Antibiotika darf man bei unkomplizierter Zystitis verwenden und wovon sollte man die Finger lassen? Welche pflanzlichen Präparate können helfen? Was taugt der zugelassene Impfstoff? Antworten vom Koordinator der frisch überarbeiteten S3-Leitlinie, Prof. Florian Wagenlehner.

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.